Jin W, Jia Y, Liao Y, Xie L, Lei X, Guo Y
Pediatr Radiol. 2025; .
PMID: 40024915
DOI: 10.1007/s00247-025-06168-8.
Katogiannis K
Medicina (Kaunas). 2025; 61(2).
PMID: 40005461
PMC: 11857355.
DOI: 10.3390/medicina61020345.
Wu Y, Lv C, Li J, Ma Y, Zhu X
Front Cardiovasc Med. 2025; 12:1515509.
PMID: 39974598
PMC: 11835890.
DOI: 10.3389/fcvm.2025.1515509.
Haesen S, Steegen L, Deluyker D, Bito V
Eur Heart J Imaging Methods Pract. 2025; 3(1):qyaf006.
PMID: 39974275
PMC: 11837189.
DOI: 10.1093/ehjimp/qyaf006.
Todo M, Gatate Y, Nakano S, Kaneko G, Hagiwara M, Takahashi T
Cancer Immunol Immunother. 2025; 74(3):97.
PMID: 39904795
PMC: 11794898.
DOI: 10.1007/s00262-025-03945-0.
Use of AI in Cardiac CT and MRI: A Scientific Statement from the ESCR, EuSoMII, NASCI, SCCT, SCMR, SIIM, and RSNA.
Mastrodicasa D, van Assen M, Huisman M, Leiner T, Williamson E, Nicol E
Radiology. 2025; 314(1):e240516.
PMID: 39873607
PMC: 11783164.
DOI: 10.1148/radiol.240516.
Anticancer-Drug-Related Cardiotoxicity from Adjuvant Goserelin and Tamoxifen Therapy.
Manfrini O, Cenko E, Bergami M, Yoon J, Kostadinovic J, Zdravkovic D
J Clin Med. 2025; 14(2).
PMID: 39860490
PMC: 11766263.
DOI: 10.3390/jcm14020484.
Matters of the Heart: Cardiotoxicity Related to Target Therapy in Oncogene-Addicted Non-Small Cell Lung Cancer.
Torresan S, Bortolot M, De Carlo E, Bertoli E, Stanzione B, Del Conte A
Int J Mol Sci. 2025; 26(2).
PMID: 39859270
PMC: 11765312.
DOI: 10.3390/ijms26020554.
The Role of Advanced Cardiac Imaging in Monitoring Cardiovascular Complications in Patients with Extracardiac Tumors: A Descriptive Review.
Tavernese A, Cammalleri V, Mollace R, Antonelli G, Piscione M, Cocco N
J Cardiovasc Dev Dis. 2025; 12(1).
PMID: 39852287
PMC: 11765722.
DOI: 10.3390/jcdd12010009.
Predicting doxorubicin-induced cardiotoxicity in breast cancer: leveraging machine learning with synthetic data.
Araujo D, Simoes R, Sabino A, Oliveira A, Oliveira C, Veloso A
Med Biol Eng Comput. 2025; .
PMID: 39828884
DOI: 10.1007/s11517-025-03289-y.
The association of BMI and subclinical myocardial dysfunction in breast cancer patients after single or dual anti-HER2 targeted therapy.
Zhang F, Wang S, Yu C, Jin W, He D, Hu X
BMC Cancer. 2024; 24(1):1585.
PMID: 39734198
PMC: 11684103.
DOI: 10.1186/s12885-024-13377-1.
Cardiovascular mortality trends and disparities in U.S. breast cancer patients, 1999-2020: a population-based retrospective study.
Yeo Y, San B, Tan J, Tan M, Donisan T, Lee J
Cardiooncology. 2024; 10(1):89.
PMID: 39696722
PMC: 11658079.
DOI: 10.1186/s40959-024-00286-2.
Cardiac Functional Assessment by Magnetic Resonance Imaging.
Jiang M, Lu M, Zhao S
Cardiol Discov. 2024; 4(4):284-299.
PMID: 39677505
PMC: 11637579.
DOI: 10.1097/CD9.0000000000000141.
Feasibility of three dimensional and strain transthoracic echocardiography in a single-centre dedicated NHS cardio-oncology clinic.
ODriscoll P, Gent D, Corbett L, Stables R, Dobson R
Echo Res Pract. 2024; 11(1):27.
PMID: 39676173
PMC: 11648287.
DOI: 10.1186/s44156-024-00063-y.
Cardioprotective strategies in the management of chemotherapy-induced cardiotoxicity: current approaches and future directions.
Al-Hasnawi Z, Hasan H, Abdul Azeez J, Kadhim N, Shimal A, Sadeq M
Ann Med Surg (Lond). 2024; 86(12):7212-7220.
PMID: 39649884
PMC: 11623821.
DOI: 10.1097/MS9.0000000000002668.
Anthracycline-Induced Subclinical Right Ventricular Dysfunction in Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Faggiano A, Gherbesi E, Giordano C, Gamberini G, Vicenzi M, Cuspidi C
Cancers (Basel). 2024; 16(22).
PMID: 39594841
PMC: 11592457.
DOI: 10.3390/cancers16223883.
Artificial intelligence: Applications in cardio-oncology and potential impact on racial disparities.
Echefu G, Shah R, Sanchez Z, Rickards J, Brown S
Am Heart J Plus. 2024; 48:100479.
PMID: 39582990
PMC: 11583718.
DOI: 10.1016/j.ahjo.2024.100479.
Cardiac function at follow-up in infants treated with therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy.
Biran V, Saba E, Lapointe A, Macias C, Mawad W, Martinez D
Pediatr Res. 2024; .
PMID: 39482497
DOI: 10.1038/s41390-024-03694-3.
Anthracycline Cardiotoxicity in Adult Cancer Patients: State-of-the-Art Review.
Camilli M, Cipolla C, Dent S, Minotti G, Cardinale D
JACC CardioOncol. 2024; 6(5):655-677.
PMID: 39479333
PMC: 11520218.
DOI: 10.1016/j.jaccao.2024.07.016.
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trial.
Marrazzo L, Meattini I, Becherini C, Salvestrini V, Visani L, Barletta G
Radiol Med. 2024; 129(12):1926-1935.
PMID: 39436588
DOI: 10.1007/s11547-024-01897-6.